Send us Feedback

GlaxoSmithKline (GSK)
Analysis
Data
Financials
Revenue by Geography    (USD)
Annual
FISCAL YEAR ENDING older 31-DEC
2004		 31-DEC
2005		 31-DEC
2006		 31-DEC
2007		 31-DEC
2008		 newer
Revenue - International 4.40B 4.90B 5.11B 5.31B 11.5B
Revenue - US 9.19B 9.87B 11.1B 10.2B 8.89B
Total Revenue 39.0B 37.3B 45.5B 45.1B 35.0B
Revenue by Segment    (USD)
Annual
FISCAL YEAR ENDING older 31-DEC
2004		 31-DEC
2005		 31-DEC
2006		 31-DEC
2007		 31-DEC
2008		 newer
Revenue - Consumer Health Care 0 0 6.37B 3.55B 3.97B
Revenue - Vaccines 0 0 3.18B 0 0
Revenue - Prescription Medication 0 0 35.9B 0 0
Revenue - Seretide/Advair 0 0 0 0 4.14B
Revenue - Flixotide/Flovent 0 0 0 0 677M
Revenue - Serevent 0 0 0 0 263M
Revenue - Veramyst 0 0 0 0 72.0M
Revenue - Flixonase/Flonase 0 0 0 0 186M
Revenue - HIV 0 0 0 0 1.51B
Revenue - Epzicom/Kivexa 0 0 0 0 442M
Revenue - Combivir 0 0 0 0 433M
Revenue - Trizivir 0 0 0 0 212M
Revenue - Agenerase, Lexiva 0 0 0 0 160M
Revenue - Epivir 0 0 0 0 139M
Revenue - Ziagen 0 0 0 0 106M
Revenue - Valtrex 0 0 0 0 1.20B
Revenue - Zeffix 0 0 0 0 188M
Revenue - Relenza 0 0 0 0 57.0M
Revenue - Lamictal 0 0 0 0 926M
Revenue - Imigran/Imitrex 0 0 0 0 687M
Revenue - Seroxat/Paxil 0 0 0 0 514M
Revenue - Wellbutrin 0 0 0 0 342M
Revenue - Requip 0 0 0 0 266M
Revenue - Requip XL 0 0 0 0 43.0M
Revenue - Treximet 0 0 0 0 25.0M
Revenue - Avodart 0 0 0 0 399M
Revenue - Lovaza 0 0 0 0 290M
Revenue - Coreg CR 0 0 0 0 165M
Revenue - Coreg IR 0 0 0 0 38.0M
Revenue - Fraxiparine 0 0 0 0 226M
Revenue - Arixtra 0 0 0 0 170M
Revenue - Vesicare 0 0 0 0 71.0M
Revenue - Levitra 0 0 0 0 60.0M
Revenue - Avandia 0 0 0 0 512M
Revenue - Avandamet 0 0 0 0 256M
Revenue - Bonviva/Boniva 0 0 0 0 237M
Revenue - Augmentin 0 0 0 0 587M
Revenue - Altabax 0 0 0 0 16.0M
Revenue - Hycamtin 0 0 0 0 140M
Revenue - Zofran 0 0 0 0 110M
Revenue - Tykerb 0 0 0 0 102M
Revenue - Hepatitis 0 0 0 0 665M
Revenue - Infanrix/Pediarix 0 0 0 0 682M
Revenue - Fluarix, FluLaval 0 0 0 0 215M
Revenue - Flu-prepandemic 0 0 0 0 66.0M
Revenue - Cervarix 0 0 0 0 125M
Revenue - Rotarix 0 0 0 0 167M
Revenue - Boostrix 0 0 0 0 70.0M
Total Revenue 39.0B 37.3B 45.5B 45.1B 35.0B
 
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki